161 related articles for article (PubMed ID: 36572608)
1. Growth differentiation factor 11: A proangiogenic drug as a potential antiaging regulating molecule.
Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
Arch Cardiovasc Dis; 2023 Jan; 116(1):41-46. PubMed ID: 36572608
[TBL] [Abstract][Full Text] [Related]
2. Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects?
Harper SC; Brack A; MacDonnell S; Franti M; Olwin BB; Bailey BA; Rudnicki MA; Houser SR
Circ Res; 2016 Apr; 118(7):1143-50; discussion 1150. PubMed ID: 27034276
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor 11: a "rejuvenation factor" involved in regulation of age-related diseases?
Ma Y; Liu Y; Han F; Qiu H; Shi J; Huang N; Hou N; Sun X
Aging (Albany NY); 2021 Apr; 13(8):12258-12272. PubMed ID: 33886503
[TBL] [Abstract][Full Text] [Related]
4. Regenerative Capacity of Endogenous Factor: Growth Differentiation Factor 11; a New Approach of the Management of Age-Related Cardiovascular Events.
Rochette L; Meloux A; Rigal E; Zeller M; Cottin Y; Malka G; Vergely C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545044
[TBL] [Abstract][Full Text] [Related]
5. TERT assists GDF11 to rejuvenate senescent VEGFR2
Zhao L; Zhang S; Cui J; Huang W; Wang J; Su F; Chen N; Gong Q
Lab Invest; 2019 Nov; 99(11):1661-1688. PubMed ID: 31292540
[TBL] [Abstract][Full Text] [Related]
6. Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?
Frohlich J; Vinciguerra M
Geroscience; 2020 Dec; 42(6):1475-1498. PubMed ID: 33025411
[TBL] [Abstract][Full Text] [Related]
7. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle.
Sinha M; Jang YC; Oh J; Khong D; Wu EY; Manohar R; Miller C; Regalado SG; Loffredo FS; Pancoast JR; Hirshman MF; Lebowitz J; Shadrach JL; Cerletti M; Kim MJ; Serwold T; Goodyear LJ; Rosner B; Lee RT; Wagers AJ
Science; 2014 May; 344(6184):649-52. PubMed ID: 24797481
[TBL] [Abstract][Full Text] [Related]
8. GDF11 does not rescue aging-related pathological hypertrophy.
Smith SC; Zhang X; Zhang X; Gross P; Starosta T; Mohsin S; Franti M; Gupta P; Hayes D; Myzithras M; Kahn J; Tanner J; Weldon SM; Khalil A; Guo X; Sabri A; Chen X; MacDonnell S; Houser SR
Circ Res; 2015 Nov; 117(11):926-32. PubMed ID: 26383970
[TBL] [Abstract][Full Text] [Related]
9. The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging.
Fan X; Gaur U; Sun L; Yang D; Yang M
Mech Ageing Dev; 2017 Jun; 164():108-112. PubMed ID: 28472635
[TBL] [Abstract][Full Text] [Related]
10. Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury.
Du GQ; Shao ZB; Wu J; Yin WJ; Li SH; Wu J; Weisel RD; Tian JW; Li RK
Basic Res Cardiol; 2017 Jan; 112(1):7. PubMed ID: 28004242
[TBL] [Abstract][Full Text] [Related]
11. GDF11 Inhibits Bone Formation by Activating Smad2/3 in Bone Marrow Mesenchymal Stem Cells.
Lu Q; Tu ML; Li CJ; Zhang L; Jiang TJ; Liu T; Luo XH
Calcif Tissue Int; 2016 Nov; 99(5):500-509. PubMed ID: 27395058
[TBL] [Abstract][Full Text] [Related]
12. GDF11/BMP11 activates both smad1/5/8 and smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells.
Zhang YH; Cheng F; Du XT; Gao JL; Xiao XL; Li N; Li SL; Dong de L
Oncotarget; 2016 Mar; 7(11):12063-74. PubMed ID: 26919250
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 11 (GDF11) has pronounced effects on skin biology.
Idkowiak-Baldys J; Santhanam U; Buchanan SM; Pfaff KL; Rubin LL; Lyga J
PLoS One; 2019; 14(6):e0218035. PubMed ID: 31181098
[TBL] [Abstract][Full Text] [Related]
14. The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis.
Egerman MA; Glass DJ
Crit Rev Biochem Mol Biol; 2019 Apr; 54(2):174-183. PubMed ID: 31144559
[TBL] [Abstract][Full Text] [Related]
15. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone.
Suh J; Kim NK; Lee SH; Eom JH; Lee Y; Park JC; Woo KM; Baek JH; Kim JE; Ryoo HM; Lee SJ; Lee YS
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4910-4920. PubMed ID: 32071240
[TBL] [Abstract][Full Text] [Related]
16. Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration.
Rochette L; Zeller M; Cottin Y; Vergely C
Pharmacol Ther; 2015 Dec; 156():26-33. PubMed ID: 26523637
[TBL] [Abstract][Full Text] [Related]
17. Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans.
Kraler S; Balbi C; Vdovenko D; Lapikova-Bryhinska T; Camici GG; Liberale L; Bonetti N; Canestro CD; Burger F; Roth A; Carbone F; Vassalli G; Mach F; Bhasin S; Wenzl FA; Muller O; Räber L; Matter CM; Montecucco F; Lüscher TF; Akhmedov A
Cardiovasc Res; 2023 Dec; 119(17):2729-2742. PubMed ID: 37742057
[TBL] [Abstract][Full Text] [Related]
18. GDF11 administration does not extend lifespan in a mouse model of premature aging.
Freitas-Rodríguez S; Rodríguez F; Folgueras AR
Oncotarget; 2016 Aug; 7(35):55951-55956. PubMed ID: 27507054
[TBL] [Abstract][Full Text] [Related]
19. Administration of rGDF11 retards the aging process in male mice via action of anti-oxidant system.
Zhou Y; Song L; Ni S; Zhang Y; Zhang S
Biogerontology; 2019 Aug; 20(4):433-443. PubMed ID: 30726519
[TBL] [Abstract][Full Text] [Related]
20. The influence of GDF11 on brain fate and function.
Schafer MJ; LeBrasseur NK
Geroscience; 2019 Feb; 41(1):1-11. PubMed ID: 30729414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
